Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

(NQ: )

N/A UNCHANGED
Last Price Updated: Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Lexicon Announces Selection Of Manuscript To Be Presented At The American Diabetes Association Diabetes Care Symposium
Results from Clinical Study of Sotagliflozin in Type 1 Diabetes Patients 
From PR Newswire
Lexicon to Present at the Bank of America Merrill Lynch 2015 Health Care Conference
From PR Newswire
Lexicon Announces One For Seven Reverse Stock Split Effective May 20, 2015
Stockholders Overwhelmingly Approved Authorization for Reverse Stock Split 
From PR Newswire
Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2015 First Quarter Financial Results
Conference Call and Webcast at 5:00 p.m. Eastern Time 
From PR Newswire
Lexicon To Report First Quarter 2015 Financial Results On April 29, 2015
Conference Call and Webcast to Follow 
From PR Newswire
Market Updates on Biotech Stocks -- Lexicon Pharma, Idera Pharma, Synta Pharma, Spectrum Pharma, and Medivation
From PR Newswire
Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research
From PR Newswire
Lexicon Pharmaceuticals and Bristol-Myers Squibb Select Development Candidate for Neuropathic Pain in Neuroscience Drug Discovery and Development Alliance
From PR Newswire
Lexicon To Present At Needham & Company's 14th Annual Healthcare Conference
From PR Newswire
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) to Ring The Nasdaq Stock Market Closing Bell
From GlobeNewswire News Releases
Lexicon Pharmaceuticals Announces First Patient Screened In Pivotal Phase 3 Clinical Trial Of Sotagliflozin
From PR Newswire
Technical Pulse on Biotech Stocks -- Geron, Lexicon Pharma, XOMA Corp., Spectrum Pharma, and BioLine RX
From PR Newswire
Lexicon and Ipsen Expand Their Licensing and Commercialization Agreement for Telotristat Etiprate to Include Canada
From PR Newswire
Advances in Biotech Expanded Studies Lead to Cutting-Edge Therapeutic Treatments - Company Announces Positive Final Results in Treatment for Alzheimer's Disease
From PR Newswire
Lexicon Pharmaceuticals Completes Enrollment In Pivotal Phase 3 Clinical Trial Of Telotristat Etiprate
Top-Line Results Expected in the 3rd Quarter of 2015 
From PR Newswire
Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2014 Fourth Quarter And Full Year Financial Results
Conference Call and Webcast at 10:00 a.m. Eastern Time 
From PR Newswire
Lexicon To Report Fourth Quarter And Year End 2014 Financial Results On March 4, 2015
Conference Call and Webcast to Follow 
From PR Newswire
Lexicon To Present At The Cowen 35th Annual Health Care Conference
From PR Newswire
Lexicon Announces Management Change
From PR Newswire
Expert Briefing on Biotech Stocks - Lexicon Pharma, Sunesis Pharma, Navidea Biopharma, Tekmira Pharma, and Intrexon
From PR Newswire
Lexicon To Present At The BIO CEO & Investor Conference
From PR Newswire
Biotech Industry Equities Under the Scanner - NPS Pharma, Mast Therapeutics, Threshold Pharma, Lexicon Pharma, and Regeneron Pharma
Editor Note: For more information about this release, please scroll to bottom. 
From PR Newswire
Lexicon To Present At The 33rd Annual J.P. Morgan Healthcare Conference
From PR Newswire
Lexicon To Present At The Oppenheimer 25th Annual Healthcare Conference
From PR Newswire
Lexicon Announces Completion Of $280 Million In Financing Transactions
From PR Newswire
Lexicon Announces Pricing Of Common Stock Offering
From PR Newswire
Lexicon Announces Pricing Of Convertible Senior Notes Offering
From PR Newswire
Lexicon Announces Proposed Common Stock Offering
From PR Newswire
Lexicon Announces Proposed Convertible Senior Notes Offering
From PR Newswire
Technical Updates on Biotech Stocks - ImmunoGen, Lexicon Pharma, ZIOPHARM Oncology, Arena Pharma, and Regulus Therapeutics
Editor Note: For more information about this release, please scroll to bottom. 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.